Skip to main content

At Tactile Medical®, a fundamental value is to earn a fair profit and return value for our shareholders


--

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming Events


NOV 08 2021 5:00 PM EST

Q3 2021 Tactile Medical Earnings Conference Call

NOV 08 2021 5:00 PM EST

Recent News


Tactile Medical to Release Third Quarter of Fiscal Year 2021 Financial Results on November 8, 2021

MINNEAPOLIS , Oct. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home, today announced that third quarter of fiscal year 2021

Read more

Tactile Medical Announces Enrollment of First Patient in Randomized, Controlled Clinical Trial Evaluating the Effectiveness of Flexitouch® Plus for the Treatment of Head and Neck Lymphedema

MINNEAPOLIS , Sept. 30, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the enrollment of the first patient in a

Read more

Tactile Medical Announces Acquisition of AffloVest®

Further expands the Company’s position as a leader in treating patients with underserved chronic conditions in the home Transaction aligns with Tactile Medical’s growth & margin goals, including 20%+ revenue growth, gross margins above 70% and expanding adjusted EBITDA margins MINNEAPOLIS , Sept.

Read more